AU2007244004B2 - Use of antisecretory factors for treating intraocular hypertension - Google Patents

Use of antisecretory factors for treating intraocular hypertension Download PDF

Info

Publication number
AU2007244004B2
AU2007244004B2 AU2007244004A AU2007244004A AU2007244004B2 AU 2007244004 B2 AU2007244004 B2 AU 2007244004B2 AU 2007244004 A AU2007244004 A AU 2007244004A AU 2007244004 A AU2007244004 A AU 2007244004A AU 2007244004 B2 AU2007244004 B2 AU 2007244004B2
Authority
AU
Australia
Prior art keywords
antisecretory
seq
use according
eye
iop
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007244004A
Other languages
English (en)
Other versions
AU2007244004A1 (en
Inventor
Hans-Arne Hansson
Eva Jennische
Stefan Lange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LANTMANNEN AS-FAKTOR AB
Original Assignee
Lantmannen AS Faktor AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmannen AS Faktor AB filed Critical Lantmannen AS Faktor AB
Publication of AU2007244004A1 publication Critical patent/AU2007244004A1/en
Assigned to LANTMANNEN AS-FAKTOR AB reassignment LANTMANNEN AS-FAKTOR AB Alteration of Name(s) of Applicant(s) under S113 Assignors: LANTMANNEN AS-FAKTOR
Application granted granted Critical
Publication of AU2007244004B2 publication Critical patent/AU2007244004B2/en
Priority to AU2012201165A priority Critical patent/AU2012201165B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AU2007244004A 2006-04-27 2007-04-27 Use of antisecretory factors for treating intraocular hypertension Ceased AU2007244004B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012201165A AU2012201165B2 (en) 2006-04-27 2012-02-28 New approach to treat intraocular hypertension

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0600932-8 2006-04-27
SE0600932 2006-04-27
PCT/SE2007/000414 WO2007126364A2 (en) 2006-04-27 2007-04-27 Use of antisecretory factors for treating intraocular hypertension

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2012201165A Division AU2012201165B2 (en) 2006-04-27 2012-02-28 New approach to treat intraocular hypertension

Publications (2)

Publication Number Publication Date
AU2007244004A1 AU2007244004A1 (en) 2007-11-08
AU2007244004B2 true AU2007244004B2 (en) 2012-02-09

Family

ID=38561776

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007244004A Ceased AU2007244004B2 (en) 2006-04-27 2007-04-27 Use of antisecretory factors for treating intraocular hypertension

Country Status (18)

Country Link
US (2) US8207296B2 (cg-RX-API-DMAC10.html)
EP (2) EP2015767B1 (cg-RX-API-DMAC10.html)
JP (2) JP5284948B2 (cg-RX-API-DMAC10.html)
KR (1) KR20090040404A (cg-RX-API-DMAC10.html)
CN (2) CN101432013B (cg-RX-API-DMAC10.html)
AU (1) AU2007244004B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0710959B8 (cg-RX-API-DMAC10.html)
CA (2) CA2771087C (cg-RX-API-DMAC10.html)
DK (2) DK2015767T3 (cg-RX-API-DMAC10.html)
ES (2) ES2773945T3 (cg-RX-API-DMAC10.html)
IL (1) IL194773A (cg-RX-API-DMAC10.html)
MX (1) MX2008013769A (cg-RX-API-DMAC10.html)
NZ (2) NZ598426A (cg-RX-API-DMAC10.html)
PL (2) PL2015767T3 (cg-RX-API-DMAC10.html)
RU (1) RU2458703C2 (cg-RX-API-DMAC10.html)
SG (1) SG171602A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007126364A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200809115B (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
JP5820277B2 (ja) 2009-02-11 2015-11-24 ラントメネン・アーエス−ファクトール・アーベー 細胞取込を最適化するための抗分泌性因子（ａｆ）の使用
WO2013050795A1 (en) * 2011-10-03 2013-04-11 Femtonics Kft. Use of photoactive compounds
NZ708860A (en) * 2012-12-20 2016-09-30 Lantmännen As Faktor Ab Use of antisecretory factor (af) in glioblastoma treatment
WO2017009004A1 (en) 2015-07-10 2017-01-19 Lantmännen As-Faktor Ab Process for producing egg yolk with high content of af-16
US11407796B2 (en) 2016-07-18 2022-08-09 Lantmännen As-Faktor Ab Antisecretory factor 17
WO2020002464A1 (en) 2018-06-28 2020-01-02 Lantmännen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
CN112770643A (zh) 2018-09-28 2021-05-07 兰特门内保健食品公司 包含麦芽化脱壳燕麦的可消耗产品
WO2020065091A1 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted wheat
EP4125984A1 (en) 2020-03-26 2023-02-08 Lantmännen Functional Foods AB A consumable product comprising malted cereals for promoting recovery at physical activity
US20240148709A1 (en) * 2022-11-08 2024-05-09 Aisa Pharma, Inc. Methods of treating eye pain and eye disorders
WO2026099453A1 (en) 2024-11-07 2026-05-15 Lantmännen Medical Ab Af-16 or af-17 for acute treatment of brain oedema in patients with traumatic brain injury

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
WO1997027296A1 (en) * 1996-01-26 1997-07-31 Hsc Research And Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
SE9604251L (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) * 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
AU5627000A (en) * 1999-06-21 2001-02-05 Inkine Pharmaceutical Company, Inc. Angiocidin: a CYS-SER-VAL-THR-CYS-GLY specific tumor cell adhesion receptor
RU2192898C1 (ru) * 2001-08-16 2002-11-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Способ лечения герпетического кератита с изъязвлением
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
KR20090037992A (ko) * 2006-04-27 2009-04-17 란트만넨 아스-팍토르 아베 항분비 단백질의 추가적 의학 용도
PL2040734T3 (pl) * 2006-04-27 2012-04-30 Lantmaennen As Faktor Ab Białko przeciwwydzielnicze do zastosowania w leczeniu zespołu przedziału

Also Published As

Publication number Publication date
US20120283191A1 (en) 2012-11-08
WO2007126364A3 (en) 2008-03-06
DK2468292T3 (da) 2020-03-23
BRPI0710959B1 (pt) 2018-11-06
IL194773A0 (en) 2011-08-01
JP5284948B2 (ja) 2013-09-11
CA2650344C (en) 2017-10-31
RU2008146733A (ru) 2010-06-10
CA2771087A1 (en) 2007-11-08
KR20090040404A (ko) 2009-04-24
EP2468292A1 (en) 2012-06-27
PL2015767T3 (pl) 2016-05-31
MX2008013769A (es) 2009-02-03
PL2468292T3 (pl) 2020-08-24
BRPI0710959B8 (pt) 2021-05-25
CN102633863B (zh) 2014-08-06
IL194773A (en) 2015-07-30
CA2771087C (en) 2016-03-15
US8207296B2 (en) 2012-06-26
US9000125B2 (en) 2015-04-07
BRPI0710959A2 (pt) 2012-02-28
EP2468292B1 (en) 2019-12-18
CN102633863A (zh) 2012-08-15
US20090162296A1 (en) 2009-06-25
SG171602A1 (en) 2011-06-29
CN101432013B (zh) 2015-01-07
EP2468292B8 (en) 2020-02-26
WO2007126364A2 (en) 2007-11-08
NZ572255A (en) 2012-03-30
AU2007244004A1 (en) 2007-11-08
WO2007126364A8 (en) 2009-07-23
EP2015767A2 (en) 2009-01-21
JP2012153695A (ja) 2012-08-16
ES2561945T3 (es) 2016-03-01
ES2773945T3 (es) 2020-07-15
DK2015767T3 (en) 2016-02-08
NZ598426A (en) 2012-08-31
EP2015767B1 (en) 2016-01-06
ZA200809115B (en) 2009-07-29
RU2458703C2 (ru) 2012-08-20
JP2009535329A (ja) 2009-10-01
CA2650344A1 (en) 2007-11-08
CN101432013A (zh) 2009-05-13

Similar Documents

Publication Publication Date Title
CA2771087C (en) Use of antisecretory factors for treating intraocular hypertension
US8487074B2 (en) Modulation of lipid rafts
AU2007244003B2 (en) Antisecretory protein for use in the treatment of compartment syndrome
JP2009535329A5 (cg-RX-API-DMAC10.html)
AU2012201165B2 (en) New approach to treat intraocular hypertension
WO2022058947A1 (en) Method of reducing intraocular pressure
HK1172553A (en) New peptide having antisecretory activity
HK1172553B (en) New peptide having antisecretory activity
HK1128237B (en) Further medical uses of antisecretory protein
JPWO2001064242A1 (ja) 網膜機能改善薬

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired